Stacy J. Park, a senior postdoctoral fellow in the department of medicine at the David Geffen School of Medicine at UCLA, has been awarded a two-year, $80,000 grant by the Prevent Cancer Foundation to study the role of electronic cigarettes (e-cigarettes) in the pathogenesis of lung cancer.
Park is developing approaches to evaluate the biological impact of new and emerging tobacco-related products to identify those most likely to pose serious health risks. Her work focuses on assessing the effect of e-cigarette exposure on cellular phenotypes related to smoking and lung cancer. The overall goal is to understand the potential damaging effects and long-term health risks of new and emerging tobacco-related products such as ECIGs.
Park holds a Ph.D. in microbiology and immunology and is a researcher in the Dubinett Lab at UCLA which performs translational lung cancer research.
